These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26400852)

  • 1. The neural correlates of anomia in the conversion from mild cognitive impairment to Alzheimer's disease.
    Pravatà E; Tavernier J; Parker R; Vavro H; Mintzer JE; Spampinato MV
    Neuroradiology; 2016 Jan; 58(1):59-67. PubMed ID: 26400852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
    Velazquez M; Lee Y;
    PLoS One; 2021; 16(4):e0244773. PubMed ID: 33914757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Li D; Yu YY; Hu N; Zhang M; Liu L; Fan LM; Ruan SS; Wang F
    Front Neurol; 2022; 13():884460. PubMed ID: 35547369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DDQ-30, a new naming-from-definition test: Normative data for the adult French-Quebec population and validation study in mild cognitive impairment and Alzheimer's disease.
    Macoir J; Febbrari R; Fiset N; Mulet-Perreault H; Laforce R; Hudon C
    Appl Neuropsychol Adult; 2024 Mar; ():1-11. PubMed ID: 38547535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N = 3,118.
    Kang X; Wang D; Lin J; Yao H; Zhao K; Song C; Chen P; Qu Y; Yang H; Zhang Z; Zhou B; Han T; Liao Z; Chen Y; Lu J; Yu C; Wang P; Zhang X; Li M; Zhang X; Jiang T; Zhou Y; Liu B; Han Y; Liu Y; ;
    Neurosci Bull; 2024 Sep; 40(9):1274-1286. PubMed ID: 38824231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Spoken Discourse and Its Neural Correlates in Women With Alzheimer's Disease With Low Levels of Education and Socioeconomic Status.
    Malcorra BLC; García AO; Marcotte K; de Paz H; Schilling LP; da Silva Filho IG; Soder R; da Rosa Franco A; Loureiro F; Hübner LC
    Am J Speech Lang Pathol; 2024 Mar; 33(2):893-911. PubMed ID: 38157526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common and proper nouns in mild Alzheimer's disease.
    Zehtab S; Moayedfar S; Ghasisin L
    Appl Neuropsychol Adult; 2024 Aug; ():1-6. PubMed ID: 39101836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indices of Regional Brain Atrophy: Formulae and Nomenclature.
    Menendez M; Arias-Carrión O
    Cureus; 2015 Aug; 7(8):e295. PubMed ID: 26261753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Alzheimer's disease signature in MR images seven years before conversion to dementia: Toward an early individual prognosis.
    Coupé P; Fonov VS; Bernard C; Zandifar A; Eskildsen SF; Helmer C; Manjón JV; Amieva H; Dartigues JF; Allard M; Catheline G; Collins DL;
    Hum Brain Mapp; 2015 Dec; 36(12):4758-70. PubMed ID: 26454259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
    Benek O; Soukup O; Pasdiorova M; Hroch L; Sepsova V; Jost P; Hrabinova M; Jun D; Kuca K; Zala D; Ramsay RR; Marco-Contelles J; Musilek K
    ChemMedChem; 2016 Jun; 11(12):1264-9. PubMed ID: 26427608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying synchrony patterns in the EEG of Alzheimer's patients with linear and non-linear connectivity markers.
    Waser M; Garn H; Schmidt R; Benke T; Dal-Bianco P; Ransmayr G; Schmidt H; Seiler S; Sanin G; Mayer F; Caravias G; Grossegger D; Frühwirt W; Deistler M
    J Neural Transm (Vienna); 2016 Mar; 123(3):297-316. PubMed ID: 26411482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.
    Cacace R; Van den Bossche T; Engelborghs S; Geerts N; Laureys A; Dillen L; Graff C; Thonberg H; Chiang HH; Pastor P; Ortega-Cubero S; Pastor MA; Diehl-Schmid J; Alexopoulos P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Sanchez-Valle R; Lladó A; Gelpi E; Almeida MR; Santana I; Tsolaki M; Koutroumani M; Clarimon J; Lleó A; Fortea J; de Mendonça A; Martins M; Borroni B; Padovani A; Matej R; Rohan Z; Vandenbulcke M; Vandenberghe R; De Deyn PP; Cras P; van der Zee J; Sleegers K; Van Broeckhoven C;
    Hum Mutat; 2015 Dec; 36(12):1226-35. PubMed ID: 26411346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating Associative Learning Effects in Patients with Prodromal Alzheimer's Disease Using the Temporal Context Model.
    Quenon L; de Xivry JJ; Hanseeuw B; Ivanoiu A
    J Int Neuropsychol Soc; 2015 Oct; 21(9):699-708. PubMed ID: 26411265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.
    Paterson RW; Toombs J; Slattery CF; Nicholas JM; Andreasson U; Magdalinou NK; Blennow K; Warren JD; Mummery CJ; Rossor MN; Lunn MP; Crutch SJ; Fox NC; Zetterberg H; Schott JM
    J Neurol; 2015 Dec; 262(12):2722-30. PubMed ID: 26410752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.
    Gauthier S; Rountree S; Finn B; LaPlante B; Weber E; Oltersdorf T
    J Alzheimers Dis; 2015; 48(2):473-81. PubMed ID: 26402011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    Rea R; Carotenuto A; Traini E; Fasanaro AM; Manzo V; Amenta F
    J Alzheimers Dis; 2015; 48(2):377-83. PubMed ID: 26402001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment.
    De Marco M; Bocchetta M; Venneri A; For The Alzheimer's Disease Neuroimaging Initiative
    Brain Sci; 2023 May; 13(5):. PubMed ID: 37239278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported word-finding complaints are associated with cerebrospinal fluid amyloid beta and atrophy in cognitively normal older adults.
    Montembeault M; Stijelja S; Brambati SM;
    Alzheimers Dement (Amst); 2022; 14(1):e12274. PubMed ID: 35155731
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.